The bacterial endotoxin test is completely harmonized in the ICH region, but the pyrogen test shows large differences which should be considered by pharmaceutical laboratories from a regulatory point of view.

1. Introduction {#sec1-toxins-10-00331}
===============

Pyrogens are defined as substances that cause exacerbate febrile reactions when sufficient amounts gain access to the circulatory system after parenteral administration or inhalation. Although "pyrogen" is a general term to define fever-producing agents ([Figure 1](#toxins-10-00331-f001){ref-type="fig"}), it is frequently used to specifically describe Gram-negative bacteria (GNB) endotoxins in the pharmaceutical industry. Other pyrogenic substances can occur, although the risks are lower \[[@B1-toxins-10-00331]\].

GNB endotoxin is a high molecular weight complex that contains lipopolysaccharide (LPS), protein, and phospholipid originating from the outer membrane of Gram-negative bacteria. Most pharmacopoeial endotoxin reference standards should be more correctly described as purified LPS since its chemical nature after purification is a lipid component called Lipid A, covalently bound to a polysaccharide composed of two parts, the core and a variable O-specific side chain, responsible for the specific immune reaction evoked in the host.

Depyrogenation is one of the most important challenges for pharmaceutical manufactures of parenteral drugs, since fever in a patient depends on the total amount of pyrogen delivered to that patient. Dry heat at temperatures above 180 °C is the method of choice for heat-resistant products, since GNB endotoxins are thermostable in the presence of moist heat and are not significantly destroyed by conventional autoclaving processes \[[@B2-toxins-10-00331]\]. Moreover, another interesting property of GNB endotoxin is its tendency to aggregate into vesicles due to the attraction between hydrophobic groups of the LPS. These vesicles are large enough to be removed by reverse-osmosis processes or size exclusion chromatography. It should be considered, that in an aqueous environment the endotoxin aggregation state depends on its surrounding environment, i.e., divalent cations such as calcium or magnesium forms larger, more stable and lower soluble endotoxin aggregates. This property can be of particular interest in depyrogenation by ultrafiltration processes. Utilizing the electrostatic properties of GNB endotoxin can offer another interesting alternative for depyrogenation. It has been described that endotoxins are positively charged at pH levels above 5, and negatively charged at pH levels under 2. This property is very useful since it accounts for the attraction that GNB endotoxins have for stationary phases in chromatographic isolation \[[@B3-toxins-10-00331]\].

The origins of the rabbit pyrogen test data back to studies by Seibert, who developed a mammalian test between 1923 and 1925, in response to concerns from surgeons about fever \[[@B4-toxins-10-00331]\]. In 1943, Welch and coworkers published two reference papers outlining the results of a collaborative study performed by the U.S. Food & Drug Administration (FDA), the National Institutes of Health (NIH), and several pharmaceutical companies \[[@B5-toxins-10-00331],[@B6-toxins-10-00331]\], resulting in the first rabbit pyrogen test (RPT) to be included in the United States Pharmacopoeia (USP). The current USP monograph, based on the evaluation of the rectal temperature of rabbits before and after an intravenous injection of a test solution into the ear, is not substantially different from the original one.

The bacterial endotoxin test (BET)---also known as LAL-test---is an alternative in vitro endotoxin assay, accepted by the main regulatory drug agencies (FDA, European Medicines Agency (EMA) or Pharmaceuticals and Medical Devices Agency (PMDA), among others). There are three techniques to perform this test, all of them based on the *Limulus* amebocyte lysate (LAL). In 1964, Levin and Bang first recognized the coagulation of the lysate in the presence of GNB endotoxin \[[@B7-toxins-10-00331],[@B8-toxins-10-00331]\]. However, some complex formulations such as radiopharmaceuticals, biotechnology formulations, etc. cannot be assayed by BET. Despite scientist having proposed several in vitro methods which are faster and more easily automated than the original LAL-tests of Cooper and Mills, the latter still remains the only official in the main pharmacopeias \[[@B9-toxins-10-00331],[@B10-toxins-10-00331],[@B11-toxins-10-00331],[@B12-toxins-10-00331],[@B13-toxins-10-00331],[@B14-toxins-10-00331],[@B15-toxins-10-00331],[@B16-toxins-10-00331],[@B17-toxins-10-00331]\].

FDA and EMA have considered the monocyte activation test (MAT) as a humane alternative method to RPT \[[@B18-toxins-10-00331],[@B19-toxins-10-00331]\]. The assay involves incubating a diluted test sample with a source of human monocytes or human monocytoid cells. Monocytes activated by pyrogens produce cytokines/interleukins that are detected in an immunological assay. Human whole blood, peripheral blood mononuclear cells (PBMC) or monocytic cell lines, are appropriate sources of monocytes and are commercially available \[[@B20-toxins-10-00331],[@B21-toxins-10-00331],[@B22-toxins-10-00331],[@B23-toxins-10-00331],[@B24-toxins-10-00331]\]. As MAT has higher sensitivity and accuracy than RPT, promises to replace it in the near future.

Although some interesting reviews about the RPT and the BET were previously published, to our knowledge, none of them provide an in-depth comparison of the two currently available official methods to evaluate pyrogenicity (RPT and BET). The goal of this review is to highlight the differences and similarities of each assay throughout the USP, European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP) and International Pharmacopoeia (IP), taking into account the current thinking of the regulatory authorities, as well as the suggestions and recommendations of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

2. In Vivo Pyrogen Assay: Rabbit Pyrogen Test (RPT) {#sec2-toxins-10-00331}
===================================================

In [Table 1](#toxins-10-00331-t001){ref-type="table"}, [Table 2](#toxins-10-00331-t002){ref-type="table"}, [Table 3](#toxins-10-00331-t003){ref-type="table"} and [Table 4](#toxins-10-00331-t004){ref-type="table"}, comparative specifications, procedures, and characteristics have been extracted from the official monographs regarding animals and good laboratory practice (GLP) conditions, temperature recording, acceptance criteria, and judgement \[[@B25-toxins-10-00331],[@B26-toxins-10-00331],[@B27-toxins-10-00331],[@B28-toxins-10-00331]\].

Among the evaluated pharmacopoeias, the most significant differences related to the experimental conditions for the animals involved in the assay are housing temperature (USP and JP the most restrictive), feeding during housing (only the EP demands a diet without antibiotics), and initial rabbit rejection reasons (the IP and the EP are the most restrictive).

For the experimental conditions regarding temperature recording, the most important differences among the selected pharmacopoeias are: the depth of the temperature recorder device, the feeding and the watering. These factors can influence the obtained results significantly.

There are also important differences in the RPT procedure among the main pharmacopoeias. From our point of view, the most important ones are the pre-training, the pre-injection conditioning time and the injecting time.

Regarding the acceptance criteria and judgement, the main differences are the number of rabbits in the extra-group and above all, the acceptance criteria.

It should be noted that the USP and the EP make some remarks about the number of rabbits, the overall treatment of the rabbits, and the replacement of the rabbit pyrogen test by an "in vitro" test. In addition, the USP is the only test to give instructions for pyrogen testing of medical devices, injection assemblies and radioactive pharmaceuticals.

3. In Vitro Pyrogen Assay: Bacterial Endotoxins Test (BET) {#sec3-toxins-10-00331}
==========================================================

Bacterial Endotoxins Test is completely harmonized according to the Q4B annex 14 published by the ICH in 2012 \[[@B29-toxins-10-00331]\]. In the IP and USP there are three possible alternatives: The gel-clot technique, which is based on gel formation; the turbidimetric technique, based on the development of turbidity after cleavage of an endogenous substrate; and the chromogenic technique, based on the development of color after cleavage of a synthetic peptide-chromogen complex \[[@B30-toxins-10-00331],[@B31-toxins-10-00331]\]. The JP outlines two detailed assays: the gel-clot techniques, which are based on gel formation by the reaction of the lysate TS with endotoxins and the photometric techniques, based on endotoxin-induced optical changes of the lysate TS. In the EP and related pharmacopoeias (The British Pharmacopoeia (BP), Real Farmacopea Española (RFE), etc.), six methods are described: Method A, or gel-clot method limit test; method B or gel-clot method quantitative test; method C, or turbidimetric kinetic method; method D or chromogenic kinetic method; method E, or chromogenic end-point method; and method F, or turbidimetric end-point method \[[@B32-toxins-10-00331],[@B33-toxins-10-00331]\]. In all the pharmacopoeias, the gel-clot limit test should be used if there are doubts about the results of the other proposed methods.

Regarding the apparatus, reagents, test solutions and determination of maximum valid dilution (MVD), no differences between the four pharmacopoeias can be determined. Authors only find little variations between JP and the other pharmacopoeias in some specific points ([Table 5](#toxins-10-00331-t005){ref-type="table"} and [Tables S1--S3](#app1-toxins-10-00331){ref-type="app"}).

4. Conclusions {#sec4-toxins-10-00331}
==============

The RPT is not harmonized between the IP and the ICH pharmacopoeias (JP, USP and EP). There are important differences in the design, procedure, temperature recording, acceptance criteria and judgement. Although the current thinking of the regulatory authorities is the transition from the in vivo test to a validated in vitro test, such as the LAL-test in accordance with 21 CFR 610.9. Nowadays, the only way for some products to demonstrate apyrogenicity during the preclinical phase is the RPT, especially if the risk assessment indicates that non-endotoxin pyrogens may be present. In Europe, the EP has an alternative test to the rabbit test. This is the monocyte activation test, a whole blood assay. Thus, pharmaceutical laboratories should consider these differences in their dossiers.

The harmonized ICH-BET, the most popular quality control endotoxin test, has as expected no significant differences across the published official monographs, and all of them may be considered interchangeable. Nevertheless, the pharmaceutical companies should demonstrate to the regulatory authorities that the selected method is acceptable and suitable for a specific material or formulation.
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![Most significant pyrogens for pharmaceutical manufacturers and sequential events of fever. GNB = Gram-negative bacteria.](toxins-10-00331-g001){#toxins-10-00331-f001}

toxins-10-00331-t001_Table 1

###### 

Experimental conditions referring to animals involved in the assay.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experimental               IP                                                              USP                                                             JP                                                 EP
  -------------------------- --------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------
  Number                     3                                                               3                                                               3                                                  3

  Condition                  Healthy                                                         Healthy                                                         Healthy                                            Healthy

  Age                        Adult                                                           Mature                                                          Mature                                             Adult

  Weight                     \-                                                              \-                                                              ≥1.5 kg                                            ≥ 1.5kg

  Sex                        \-                                                              \-                                                              \-                                                 either

  Variety                    The same, ideally                                               \-                                                              \-                                                 \-

  **Housing:**                                                                                                                                                                                                  

  temperature                uniform (±2 °C)                                                 uniform (20--23 °C) (±3 °C)                                     constant = 20 °C--27 °C                            uniform, appropriate

  humidity                   uniform                                                         \-                                                              \-                                                 \-

  watering                   *ad libitum*                                                    \-                                                              \-                                                 \-

  feeding                    usual food *ad libitum*                                         \-                                                              constant diet                                      complete, balanced, antibiotics free diet

  Environs                   Not exciting                                                    Not exciting                                                    Not exciting                                       Quiet

  Individually or in group   Individually                                                    Individually                                                    Individually                                       Individually

  Rejection reasons          ▪ Last use, in a pyrogen test, in the last 48 h\                ▪ Last use, in a pyrogen test, in the last 48 h\                ▪ Last use, in a pyrogen test, in the last 48 h\   ▪ Loss of body mass in the previous week\
                             ▪ T rise in the last test ≥ 0.5 °C\                             ▪ T rise ≥ 0.6 °C in a pyrogen test in the previous 2 weeks\    ▪ Last use in a pyrogen-positive test\             ▪ Last use, in a pyrogen test, in the last 3 days\
                             ▪ Last use in a pyrogen-positive test in the previous 2 weeks   ▪ Last use in a pyrogen-positive test in the previous 2 weeks   ▪ Loss of body mass in the previous week           ▪ Last use, in a pyrogen-positive test, in the last 3 weeks\
                                                                                                                                                                                                                ▪ Use, in a pyrogen test, where the rabbits' temperature mean rise \> 1.2 °C
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IP: International Pharmacopoeia; USP: United States Pharmacopoeia; JP: Japanese Pharmacopoeia; EP: European Pharmacopoeia.

toxins-10-00331-t002_Table 2

###### 

Experimental conditions referring to temperature recording in the rabbit pyrogen test (RPT).

  Experimental     IP                                           USP                                                                    JP                                                   EP
  ---------------- -------------------------------------------- ---------------------------------------------------------------------- ---------------------------------------------------- ------------------------------------------------------------------------------
  Test room        Housing area or similar separate room        Separate area designated solely for pyrogen testing                    Separate room                                        Housing area or separate room (at least 18h of previous staying)
  Room T           Similar to the housing T                     Similar to the housing T                                               Similar to the housing T                             Within 3 °C of the housing T
  Instrument       Accurate thermometer or T-recording device   Accurate T-sensing device (clinical thermometer or thermistor probe)   Rectal thermometer or T-measuring apparatus          Thermometer or electrical device
  Precision        0.1 °C                                       ± 0.1 °C                                                               ≤ ± 0.1 °C                                           0.1 °C
  Time             Sufficient to reach a maximum T              Sufficient to reach a maximum T and \< 5 min                           \-                                                   An electrical device may be left throughout the test.
  Site and depth   Rectum, ≈ 6 cm                               Rectum, ≥ 7.5 cm                                                       Rectum, 6--9 cm constant                             Rectum, ≈ 5 cm constant
  Restraint        By a loosely fitting neck stock              With lightly fitting neck stock                                        By a loosely fitting neck stock                      By a loosely fitting neck stock (at least 1h before and throughout the test)
  Posture          Natural resting                              Natural resting                                                        Natural resting                                      Normal
  Feeding          Not allowed (2h before and during test)      Not allowed                                                            Not allowed (several hours before and during test)   Not allowed (previous overnight and during test)
  Watering         Allowed                                      Allowed, may be restricted                                             \-                                                   Not allowed

T: temperature; IP: International Pharmacopoeia; USP: United States Pharmacopoeia; JP: Japanese Pharmacopoeia; EP: European Pharmacopoeia.

toxins-10-00331-t003_Table 3

###### 

RPT procedure.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experimental                                  IP                                                                                               USP                                                                                            JP                                                                                               EP
  --------------------------------------------- ------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------
  Pretraining for rabbits not previously used   Same test omitting the injection, 1--3 days before                                               Same test omitting the injection, not more than 7 days before; for rabbits never used before   Same test omitting the injection, 1--3 days before                                               Same test injecting pyrogen-free 9 g/L solution of sodium chloride R, 1--3 days before.\
                                                                                                                                                                                                                                                                                                                                                 Non-use period = 2 weeks

  Pre-injection conditioning time               ≥ 1 h                                                                                            \-                                                                                             ≥ 48 h                                                                                           18 h

  Control T (CT)                                Mean of two T readings (T1, T2) at an interval of 30 min in the 40 min preceding the injection   Taken no more than 30 min prior to the injection                                               Mean of two T readings (T1, T2) at an interval of 30 min in the 40 min preceding the injection   Mean of two T readings (T1, T2) at an interval of 30 min in the 40 min preceding the injection

  Rabbit selection criteria                     ▪ ΔCT among rabbits ≤ 1.0 °C\                                                                    ▪ ΔCT among rabbits ≤ 1.0 °C\                                                                  ▪ T1-T2 ≤ ± 0.2 °C\                                                                              ▪ ΔT ≤ 0.6 °C in the pretraining\
                                                ▪ T1-T2 ≤ mean ± 0.2 °C\                                                                         ▪ CT \< 39.8 °C                                                                                ▪ CT ≤ 39.8 °C                                                                                   ▪ T1-T2 ≤ ± 0.2 °C\
                                                ▪ 38 °C ≤ CT ≤ 39.8 °C                                                                                                                                                                                                                                                                           ▪ 38 °C ≤ CT ≤ 39.8 °C\
                                                                                                                                                                                                                                                                                                                                                 ▪ ΔCT among rabbits ≤ 1.0 °C

  Syringe, needle and glassware                 Free of pyrogens by any suitable method\                                                         Free of pyrogens by any suitable method\                                                       Free of pyrogens                                                                                 Thorough wash and heating in a hot-air oven (250 °C, 30 min or 200 °C, 1h)
                                                (250 °C, 30 min)                                                                                 (250 °C, 30 min)                                                                                                                                                                                

  Test material                                 Solution of the substance being examined                                                         Either the product or the product treated as directed in the monograph                         Solution of the substance being examined. When hypotonic, may be made isotonic.                  Sterile solution of the substance being examined

  Tested product amount                         As specified in the monograph                                                                    As prescribed in the monograph                                                                 \-                                                                                               As prescribed in the monograph

  Volume injected                               10 mL/kg (or as specified in the monograph)                                                      10 mL/kg (or as specified in the monograph)                                                    10 mL/kg (or as specified in the monograph)                                                      0.5 mL/kg--10 mL/kg

  Test solution T                               ≈ 38 °C                                                                                          37 °C ± 2 °C                                                                                   37 °C ± 2 °C                                                                                     ≈ 38 °C

  Injection site                                Marginal vein of the ear                                                                         Ear vein                                                                                       Marginal vein of the ear                                                                         Marginal vein of the ear

  Injecting time                                ≤ 4 min (or as specified in the monograph)                                                       ≤ 10 min                                                                                       ≤ 10 min                                                                                         ≤ 4 min (or as specified in the monograph)

  Measurement period, after injection           3 h                                                                                              3 h                                                                                            3 h                                                                                              3 h

  Measurement frequency                         Continuously or every 30 min                                                                     Every 30 min between 1 and 3 h subsequent to the injection                                     ≤ 30 min                                                                                         ≤ 30 min (starting at least 90 min before the injection)

  Rabbit T rise (TR) = response                 ▪ TR = T~max~ − CT\                                                                              ▪ TR = T − CT\                                                                                 ▪ TR = T~max~ − CT\                                                                              ▪ TR = T~max~ − CT\
                                                ▪ TR = 0 when T~max~ \< CT (T~max~ = maximum T recorded after injection/rabbit)                  ▪ TR = 0 when T \< CT\                                                                         ▪ TR = 0 when T~max~ \< CT (T~max~ = maximum T recorded after injection/rabbit)                  ▪ TR = 0 when T~max~ \< CT (T~max~ = maximum T recorded after injection/rabbit)
                                                                                                                                                 (T = any T recorded after injection/rabbit)                                                                                                                                                     
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

T: temperature; IP: International Pharmacopoeia; USP: United States Pharmacopoeia; JP: Japanese Pharmacopoeia; EP: European Pharmacopoeia

toxins-10-00331-t004_Table 4

###### 

RPT acceptance criteria and judgement.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experimental                        IP                                                                            USP                                                                           JP                                    EP
  ----------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------- ---------------------------------------------------------------------------
  Number of rabbits extra-groups      1                                                                             1                                                                             Up to 2                               Up to 3

  Number of rabbits per extra-group   5                                                                             5                                                                             3                                     3

  Case 1 and judgment                 ▪ No individual TR ≥ 0.6 °C **and** Σ TR ≤ 1.4 °C\                            ▪ No individual TR ≥ 0.5 °C\                                                  ▪ Σ TR ≤ 1.3 °C\                      ▪ Σ TR (n = 3, 6, 9 or 12) ≤ 1.15, 2.80, 4.45 or 6.60 (°C) respectively\
                                      ▪ Absence of pyrogens                                                         ▪ Absence of pyrogens                                                         ▪ Pyrogen-negative                    ▪ Product passes

  Case 2 and judgment                 ▪ 1 or 2 individual TR ≥ 0.6 °C **or** Σ TR (n = 3) \> 1.4 °C\                ▪ Any individual TR ≥ 0.5 °C\                                                 ▪ Σ TR \> 2.5 °C\                     ▪ Σ TR (n = 3, 6, 9 or 12) \> 2.65, 4.30, 5.95 or 6.60 (°C) respectively\
                                      ▪ Test 5 other rabbits                                                        ▪ Test 5 other rabbits                                                        ▪ Pyrogen-positive                    ▪ Product fails

  Case 3 and judgment                 ▪ Not more than 3 of the TR (n = 8) ≥ 0.6 °C **and** Σ TR (n = 8) ≤ 3.7 °C\   ▪ Not more than 3 of the TR (n = 8) ≥ 0.5 °C **and** Σ TR (n = 8) ≤ 3.3 °C\   ▪ 1.3 °C \< Σ TR \< 2.5 °C\           ▪ Σ TR does not meet neither case 1 nor case 2\
                                      ▪ Absence of pyrogens                                                         ▪ Absence of pyrogens                                                         ▪ Test 3 other rabbits                ▪ Test 3 other rabbits up to 12

  Case 4 and judgment                 \-                                                                            \-                                                                            ▪ Σ TR (n = 6) ≤ 3.0 °C\              \-
                                                                                                                                                                                                  ▪ Pyrogen-negative                    

  Case 5 and judgment                 \-                                                                            \-                                                                            ▪ Σ TR (n = 6) \> 4.2 °C\             \-
                                                                                                                                                                                                  ▪ Pyrogen-positive                    

  Case 6 and judgment                 \-                                                                            \-                                                                            ▪ 3.0 °C \< Σ TR (n = 6) \< 4.2 °C\   \-
                                                                                                                                                                                                  ▪ Test 3 other rabbits                

  Case 7 and judgment                 \-                                                                            \-                                                                            ▪ Σ TR (n = 9) ≤ 5.0 °C\              \-
                                                                                                                                                                                                  ▪ Pyrogen-negative                    

  Case 8 and judgment                 \-                                                                            \-                                                                            ▪ Σ TR (n = 9) \> 5.0 °C\             \-
                                                                                                                                                                                                  ▪ Pyrogen-positive                    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TR. Rabbit temperature rise; IP: International Pharmacopoeia; USP: United States Pharmacopoeia; JP: Japanese Pharmacopoeia; EP: European Pharmacopoeia.

toxins-10-00331-t005_Table 5

###### 

Differences in harmonized bacterial endotoxins test (BET) between JP and IP, USP and EP.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experimental                                        IP-USP-EP                                                                        JP
  --------------------------------------------------- -------------------------------------------------------------------------------- --------------------------------------------------------------------------------
  Gel-clot techniques: valid test conditions          The lowest concentration of the standard solutions shows a (-) result            When 0.25λ of the standard solution shows a (-) result

  Photometric quantitative techniques: requirements   ▪ Sol. C comply assurance of criteria\                                           ▪ \|r\| of sol. C: ≥ 0.980\
                                                      ▪ endotoxin recovery: 50--200%\                                                  ▪ endotoxin recovery: 50--200%\
                                                      ▪ Sol. D: ≤ blank value of the lysate employed or \< endotoxin detection limit   ▪ Sol. D: ≤ blank value of the lysate employed or \< endotoxin detection limit
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IP: International Pharmacopoeia; USP: United States Pharmacopoeia; JP: Japanese Pharmacopoeia; EP: European Pharmacopoeia.
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